This is the authors' abstract. We don't add key points for this paper.
Allosteric transcription factor (aTF) based biosensors can be used to engineer genetic circuits for a wide range of applications. The literature and online databases contain hundreds of experimentally validated molecule-TF pairs, however the knowledge is scattered and often incomplete. Additionally, compared to the number of compounds that can potentially be produced using living systems, the number of those discovered with TF-based interactions is low. For these reasons, new tools that help researchers find new possible TF-ligand pairs are called for. In this work we present Sensbio ( https://bit.ly/3OF4msH ), an online web server that through similarity comparison against a TF-ligand reference database, is able to identify putative transcription factors that may be activated by a given input molecule. As a complement to the application, a predictive model has been developed to find new possible matches based on machine learning.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tellechea‐Luzardo et al. (2022) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: